Bharat Immunologicals & Biologicals Corporation Ltd. benchmarking: Perfomance to industry peers

Financial

	Bharat Immunological	Makers Laboratories	Biofil Chem & Pharma
Operational Metrics
Financials
5 yr Average ROE	-29.83 %	0.31 %	4.39 %
5yr average Equity Multiplier	3.08	2.36	2.06
5yr Average Asset Turnover Ratio	0.61	0.7	0.95
5yr Avg Net Profit Margin	-18.38 %	-0.21 %	2.38 %
Price to Book	1.13	1.11	3.41
P/E	0.0	8.75	22.72
5yr Avg Cash Conversion Cycle	206.63 Days	75.08 Days	75.63 Days
Inventory Days	125.06 Days	107.1 Days	28.27 Days
Days Receivable	61.4 Days	71.83 Days	389.8 Days
Days Payable	117.81 Days	106.28 Days	203.89 Days
5yr Average Interest Coverage Ratio	-2.32	4.73	23.53
5yr Avg ROCE	-44.64 %	6.35 %	6.37 %
5yr Avg Operating Profit Margin	-18.7 %	7.59 %	3.78 %
5 yr average Debt to Equity	0.71	0.21	0.03
5yr CAGR Net Profit	23.51 %	n/a	-14.7 %
5yr Average Return on Assets	-10.1 %	0.25 %	2.37 %
Shareholdings
Promoter Holding	59.25 %	61.27 %	46.79 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bharat Immunological	Makers Laboratories	Biofil Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Oral Polio Vaccine 100.0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Services 0 Chemicals 0 Generic Formulation 0 Chemicals Div 0 Pharma Div 0	Product Wise Break-Up Chemicals Div 0 Formulation 28.7 Pharma Div 0 Chemicals 63.85 Zinc Tablets 0 Services 6.85 BIBSANIT 0 BIB VIT 0 Oral Polio Vaccine 0 Others 0.6	Product Wise Break-Up Chemicals 24.64 Generic Formulation 0 Pharmaceuticals 75.36 Chemicals 0 Zinc Tablets 0 Services 0 BIBSANIT 0 BIB VIT 0 Oral Polio Vaccine 0
Asset Break-Up	Asset Break-Up Oral Polio Vaccine 94.18 Zinc Tablets 0.04 BIB sweets Tablets 0 Chemicals 0 Pharmaceuticals 0 Others 5.78	Asset Break-Up Chemicals 66.17 Zinc Tablets 0 Pharmaceuticals 33.83 BIB sweets Tablets 0 Oral Polio Vaccine 0	-